LRRK2 in Parkinson disease: challenges of clinical trials
LRRK2 in Parkinson disease: challenges of clinical trials
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
One of the most common monogenic forms of Parkinson disease (PD) is caused by mutations in the
LRRK2
gene that encodes leucine-rich repeat kinase 2 (LRRK2).
LRRK2
mutations, and particularly the most common mutation Gly2019Ser, are observed in patients with autosomal dominant PD and in those with apparent sporadic PD, who are clinically...
Alternative Titles
Full title
LRRK2 in Parkinson disease: challenges of clinical trials
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2345506522
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2345506522
Other Identifiers
ISSN
1759-4758
E-ISSN
1759-4766
DOI
10.1038/s41582-019-0301-2
